These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 7349323)

  • 1. Pharmacokinetic studies of theophylline in dogs.
    McKiernan BC; Neff-Davis CA; Koritz GD; Davis LE; Pheris DR
    J Vet Pharmacol Ther; 1981 Jun; 4(2):103-10. PubMed ID: 7349323
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetic studies of theophylline in cats.
    McKiernan BC; Koritz GD; Davis LE; Neff-Davis CA; Pheris DR
    J Vet Pharmacol Ther; 1983 Jun; 6(2):99-104. PubMed ID: 6887346
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the bioavailability and pharmacokinetics of two extended-release theophylline formulations in dogs.
    Bach JE; Kukanich B; Papich MG; McKiernan BC
    J Am Vet Med Assoc; 2004 Apr; 224(7):1113-9. PubMed ID: 15074856
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics and bioavailability of theophylline in horses.
    Errecalde JO; Button C; Baggot JD; Mulders MS
    J Vet Pharmacol Ther; 1984 Dec; 7(4):255-63. PubMed ID: 6512916
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetic studies of theophylline in horses.
    Ingvast-Larsson C; Paalzow G; Paalzow L; Ottosson T; Lindholm A; Appelgren LE
    J Vet Pharmacol Ther; 1985 Mar; 8(1):76-81. PubMed ID: 3989903
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetic disposition of an immediate-release aminophylline and a sustained-release theophylline formulation in the horse.
    Goetz TE; Munsiff IJ; McKiernan BC
    J Vet Pharmacol Ther; 1989 Dec; 12(4):369-77. PubMed ID: 2614856
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A cross-over study of oral and intravenous administration of theophylline in male volunteers. Absolute bioavailability of theophylline tablets.
    Kaumeier HS; Kehrhahn OH; Neugebauer G; Schuppan D; Schwarz JA; Staib AH
    Arzneimittelforschung; 1984; 34(1):92-5. PubMed ID: 6538428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Theophylline bioavailability in the dog.
    Tse FL; Szeto DW
    J Pharm Sci; 1982 Nov; 71(11):1301-3. PubMed ID: 7175732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of theophylline in beagle dogs and asthmatic patients after multiple oral doses of sustained-release theophylline tablet formulation.
    Nosaka H; Takagi K; Hasegawa T; Ogura Y; Mizukami Y; Satake T
    Int J Clin Pharmacol Ther Toxicol; 1986 Oct; 24(10):528-35. PubMed ID: 3781672
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Theophylline pharmacokinetics in Thai children.
    Vichyanond P; Aranyanark N; Visitsuntorn N; Tuchinda M
    Asian Pac J Allergy Immunol; 1994 Dec; 12(2):137-43. PubMed ID: 7612107
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bioavailability of theophylline from a sustained-release aminophylline formulation (Euphyllin retard tablets)--plasma levels after single and multiple oral doses.
    Schuppan D; Molz KH; Staib AH; Rietbrock N
    Int J Clin Pharmacol Ther Toxicol; 1981 May; 19(5):223-7. PubMed ID: 7251238
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bioavailability of Theodel, a new theophylline tablet, in humans.
    Rovei V; Strolin Benedetti M; Donath A; Grenot C; Chanoine F
    Int J Clin Pharmacol Ther Toxicol; 1983 Aug; 21(8):425-30. PubMed ID: 6629546
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of caffeine on circulating theophylline levels in beagle dogs.
    Tse FL; Valia KH; Szeto DW; Raimondo TJ; Koplowitz B
    J Pharm Sci; 1981 Apr; 70(4):395-9. PubMed ID: 7229951
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Theophylline absorption and disposition in rabbits: oral, intravenous, and concentration-dependent kinetic studies.
    El-Yazigi A; Sawchuk RJ
    J Pharm Sci; 1981 Apr; 70(4):452-6. PubMed ID: 7229966
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bioavailability and pharmacokinetics of theophylline in plain uncoated and sustained-release dosage forms in relation to smoking habit. I. Single dose study.
    Horai Y; Ishizaki T; Sasaki T; Chiba K; Suganuma T; Echizen H; Ohnishi A
    Eur J Clin Pharmacol; 1983; 24(1):79-87. PubMed ID: 6832206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The absolute bioavailability of a new pediatric sustained release theophylline tablet, when given as whole or divided tablets.
    Jonkman JH; van der Boon WJ; Schoenmaker R; Holtkamp A; Thürkow-Luikens AJ
    Int J Clin Pharmacol Ther Toxicol; 1984 Sep; 22(9):506-10. PubMed ID: 6500770
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Theophylline bioavailability: a comparison of the oral absorption of a theophylline elixir and two combination theophylline tablets to intravenous aminophylline.
    Fixley M; Shen DD; Azarnoff DL
    Am Rev Respir Dis; 1977 Jun; 115(6):955-62. PubMed ID: 262107
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Bioavailability of a delayed-action aminophylline preparation].
    Regazzi MB; Guarnone E; Bartoli A; Ciardelli L; Piacentini P
    Minerva Med; 1985 Mar; 76(13):641-5. PubMed ID: 3991030
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative bioavailability of a microcrystalline theophylline tablet and uncoated aminophylline tablets.
    Sansom LN; Milne RW; Cooper D
    Eur J Clin Pharmacol; 1979; 16(6):417-21. PubMed ID: 583332
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronopharmacokinetics of theophylline after sustained release and intravenous administration to adults.
    Jonkman JH; van der Boon WJ; Balant LP; Schoenmaker R; Holtkamp A
    Eur J Clin Pharmacol; 1984; 26(2):215-22. PubMed ID: 6723760
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.